CatSci is an innovative scientific partner dedicated to transforming drug development.
Founded in 2010 by former AstraZeneca scientists, the company has evolved from a catalyst screening specialist to a fully integrated drug development partner.
Operating across 14 state-of-the-art laboratories in the UK and Europe, CatSci collaborates with over 100 biotech and global pharma companies.
They foster a culture of continuous improvement, where employees from diverse backgrounds can flourish, thus enhancing the strength of the organisation.